Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
44.90
+2.29 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
45.00
+0.10 (0.22%)
After-hours: Dec 5, 2025, 7:55 PM EST
Vera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,870 | 2,678 | 683 | 535 | 569 | - | |
| Market Cap Growth | -1.24% | 291.87% | 27.69% | -5.87% | - | - | |
| Enterprise Value | 2,450 | 2,380 | 553 | 433 | 482 | - | |
| Last Close Price | 44.90 | 42.29 | 15.38 | 19.35 | 26.72 | - | |
| PB Ratio | 7.19 | 4.64 | 6.72 | 6.96 | 8.17 | - | |
| P/TBV Ratio | 7.20 | 4.64 | 6.72 | 6.96 | 8.17 | - | |
| Debt / Equity Ratio | 0.19 | 0.10 | 0.53 | 0.41 | 0.07 | - | |
| Quick Ratio | 11.96 | 25.41 | 7.23 | 4.48 | 10.36 | 22.36 | |
| Current Ratio | 12.21 | 25.67 | 7.71 | 4.91 | 10.73 | 22.55 | |
| Return on Equity (ROE) | -73.25% | -44.83% | -107.50% | -121.58% | -54.43% | -198.65% | |
| Return on Assets (ROA) | -38.12% | -25.14% | -41.54% | -52.81% | -31.09% | -102.70% | |
| Return on Capital (ROIC) | -41.18% | -26.55% | -48.38% | -62.19% | -34.47% | -114.19% | |
| Return on Capital Employed (ROCE) | -56.80% | -26.50% | -66.60% | -85.90% | -45.20% | -94.40% | |
| Earnings Yield | -8.78% | -5.68% | -14.05% | -16.64% | -5.74% | - | |
| FCF Yield | -7.37% | -5.07% | -13.50% | -12.64% | -4.17% | - | |
| Buyback Yield / Dilution | -22.89% | -29.55% | -60.73% | -97.76% | -4099.14% | -8.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.